Insulet (PODD) Operating Income (2010 - 2026)
Insulet (PODD) posted Operating Income of $122.1 million for Q1 2026, down 16.54% on a QoQ basis from $146.3 million in Q4 2025, and up 37.5% year-over-year from $88.8 million in Q1 2025.
Insulet (PODD) Operating Income (2010 - 2026) Analysis & Trends
Insulet's Operating Income history runs 17 years deep, the most recent figure standing at $122.1 million for Q1 2026.
- Quarterly Operating Income rose 37.5% year-over-year to $122.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $507.2 million (up 48.87% YoY) and the FY2025 annual result came in at $473.8 million, up 53.38% from the prior year.
- Operating Income was $122.1 million for Q1 2026 at Insulet, down from $146.3 million in the prior quarter.
- Across five years, Operating Income topped out at $146.3 million in Q4 2025 and bottomed at -$26.7 million in Q2 2022.
- A 5-year average of $68.4 million and a median of $56.9 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 201.52% — and 2023, when it jumped 1789.66%.
- Insulet's Operating Income stood at $23.5 million in 2022, then surged by 353.19% to $106.5 million in 2023, then advanced by 2.63% to $109.3 million in 2024, then jumped by 33.85% to $146.3 million in 2025, then declined by 16.54% to $122.1 million in 2026.
- Business Quant data shows PODD's Operating Income at $122.1 million in Q1 2026, $146.3 million in Q4 2025, and $117.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Insulet | 11.08 Bn | 10.60 Bn | 529.10 Mn | 122.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.10 Mn |
| Dec 31, 2025 | 146.30 Mn |
| Sep 30, 2025 | 117.70 Mn |
| Jun 30, 2025 | 121.10 Mn |
| Mar 31, 2025 | 88.80 Mn |
| Dec 31, 2024 | 109.30 Mn |
| Sep 30, 2024 | 88.10 Mn |
| Jun 30, 2024 | 54.50 Mn |
| Mar 31, 2024 | 56.90 Mn |
| Dec 31, 2023 | 106.50 Mn |
| Sep 30, 2023 | 54.80 Mn |
| Jun 30, 2023 | 31.10 Mn |
| Mar 31, 2023 | 27.70 Mn |
| Dec 31, 2022 | 23.50 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | -26.70 Mn |
| Mar 31, 2022 | 37.90 Mn |
| Dec 31, 2021 | 49.70 Mn |
| Sep 30, 2021 | 33.70 Mn |
| Jun 30, 2021 | 26.30 Mn |